<DOC>
	<DOCNO>NCT00216749</DOCNO>
	<brief_summary>This multicenter , open-label , prospective study cilostazol use prevention recurrence patient cerebral infarction .</brief_summary>
	<brief_title>Efficacy Safety Cilostazol Indication CSPS</brief_title>
	<detailed_description>This multicenter , open-label , prospective study cilostazol use prevention recurrence patient cerebral infarction . Qualified patient treat cilostazol physician 's assessment . This study continue 4 year . More 600 patient 4 year .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Patient experience cerebral infarction purpose prevention recurrence cerebral infarction . Age : 18 year age Unqualified patient judge study investigator ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Cerebral Infarction Prevention</keyword>
	<keyword>Cilostazol</keyword>
</DOC>